Dr. Salem I. Noureldine is a fellowship-trained Endocrine Surgeon and Assistant Professor of Surgery at the George Washington University School of Medicine and Health Sciences, where he also serves as Associate Program Director for the General Surgery Residency Program. He is the only dedicated and the highest-volume thyroid, parathyroid, and adrenal surgeon at George Washington University and among the few surgeons nationwide to hold a Focused Practice Designation from the American Board of Surgery in thyroid and parathyroid surgery. His high-volume clinical practice encompasses benign, functional, and malignant diseases of the thyroid, parathyroid, and adrenal glands, as well as neuroendocrine tumors of the pancreas.
Dr. Noureldine earned his medical degree from Aleppo University Faculty of Medicine and completed postdoctoral fellowships in Endocrine Surgery at Tulane University and Johns Hopkins University. Under the mentorship of leaders in the field, he developed an early interest in complex endocrine pathology and conducted seminal research investigating the role of diagnostic and prognostic molecular markers of thyroid cancer, the effect of targeted therapies in aggressive thyroid carcinoma, novel noninvasive ablative techniques of thyroid tumors, atypical presentations of hyperparathyroidism, and participated in outcomes studies aimed at improving care for patients with thyroid, parathyroid, and adrenal disease.
After graduating with distinction from surgical residency at George Washington University, he pursued advanced fellowship training in Endocrine Surgery at the Cleveland Clinic and later practiced at the Cleveland Clinic’s Endocrine and Metabolism Institute before returning to Washington, DC. His surgical expertise includes conventional, minimally invasive, and robotic approaches, with a strong emphasis on emerging technologies such as “scarless” thyroidectomy, radiofrequency ablation, and fluorescence-guided surgery.
An accomplished academic surgeon, Dr. Noureldine has co-authored thyroid cancer management guidelines for the American Head and Neck Society and published over 75 peer-reviewed manuscripts and multiple textbook chapters. His research, cited more than 3,000 times, has advanced the understanding of molecular diagnostics, optimized surgical outcomes, refined the management of hyperparathyroidism, and introduced innovative ablative therapies into clinical practice. He has presented nationally and internationally, and serves as editor and reviewer for leading surgical journals.
Dr. Noureldine holds operative privileges at George Washington University Hospital, Virginia Hospital Center, and Reston Hospital Center, and maintains active practices in Washington, DC, Reston, and Alexandria, VA.
He is an active member of the American College of Surgeons, American Association of Endocrine Surgeons, American Thyroid Association, and American Head and Neck Society. He has served on multiple national committees and currently chairs the American Thyroid Association’s consensus statement on outpatient thyroidectomy.
He lives in Northern Virginia with his wife and two sons, and enjoys playing tennis and spending time outdoors with his family.
